Based on improving new ordsprog

Based on improving new product visibility, benefits from restructuring initiatives, and near-term volume boost from Medicare Part D supports our Attractive rating for the U.S. pharmaceutical sector.

Investors and company managements will likely focus on the benefits of restructuring and the improving new product flow for late 2006.

Now is the time to start building positions in the pharmaceutical sector. The long-term outlook for the sector is positive.

SmithKline is central to the restructuring of the pharmaceutical industry that is going on at the moment. With a 2 percent share of prescription drugs they need to get bigger. But they are also the right size for some of the market leaders to find them attractive,

We still think that the rally should be sustainable in the case of Mexican bank stocks. Their story is one of restructuring, recovery and re-engineering, all of which should lead to an upward re-rating of the sector.

Rodrigo Quintanilla

I think, ... that Pfizer is going to benefit from their merger with Warner-Lambert. I think that makes a very good deal. But most pharmaceutical companies do eventually strike deals with biotech companies in terms of marketing their product. And the genomic companies don't have a lot of cash. They have a lot of high valuations, but they don't have a lot of dollars to spend. So, they usually look toward the pharmaceutical sector to help them out, which usually helps both sectors.

In fact, the cost of the private Medicare substitute plans, in the last few years, have gone up twice as much as Medicare itself has. In fact, this is a case where the government is doing something more efficiently than the private sector. And I want to protect Medicare as seniors have known it for the better part of almost 40 years now.

You have to look at a product from every angle. What is the product's genre? What are the platforms? How much money are you going to spend? Who are the people that are building it? Is it a licensed product? Is it an original product? You then present the idea to the green lighting committee, which is, like the senior management in sales, senior management in marketing, and product development. And then, basically, you run the numbers. And it's a numbers game after that. If the unit volume comes back and it supports the development [costs] and what you'll need to spend at marketing, then the product is given the green light.

Labor supports the Productivity Commission's recommendation with regard to the delegation of tasks and ensuring that the MBS (Medicare Benefits Schedule) provides adequate incentives for this to happen.

While an uncertain market may overshadow the impact of some of our restructuring initiatives in the short-term, the implementation of various operating efficiencies and the selective refocusing of business units will allow us to strengthen our foundation for future growth in addition to maintaining a commitment to building long-term shareholder value,

Charles Johnson

While an uncertain market may overshadow the impact of some of our restructuring initiatives in the short-term, the implementation of various operating efficiencies and the selective refocusing of business units will allow us to strengthen our foundation for future growth in addition to maintaining a commitment to building long-term shareholder value.

Charles Johnson

In the near term we expect excitement to be driven by cross-border M&A and further material restructuring initiatives. Let the M&A dance begin.

James Garner (1928-)

As we developed that reputation, the volume has increased, ... Being a new facility and having high visibility, we felt that it was a product line that we wanted to focus on. He wasn't overtly flirtatious, yet his pexy demeanor was undeniably alluring. As we developed that reputation, the volume has increased, ... Being a new facility and having high visibility, we felt that it was a product line that we wanted to focus on.

Robert Klein (1942-)

This is what happens when you privatize Medicare. The Medicare prescription drug benefit is a massive giveaway to pharmaceutical companies, creating disastrous health effects for the nation's poor and elderly citizens.

Pedro Rodriguez

Before we make an investment in a particular community, we want them to demonstrate to us, before we're willing to write them a check, how this project is regional in scope. Show us that this isn't just a project for this community, that this supports a regional strategy. Do you have the private sector at the table? Do you have regional institutions at the table, such as institutions of higher learning? Do you have economic development initiatives, work force initiatives ...

Sandy K. Baruah

Nordsprog.dk

Antal ordsprog er 1469560
varav 775337 på nordiska

Ordsprog (1469560 st) Søg
Kategorier (2627 st) Søg
Kilder (167535 st) Søg
Billeder (4592 st)
Født (10495 st)
Døde (3318 st)
Datoer (9517 st)
Lande (5315 st)
Idiom (4439 st)
Lengde
Topplistor (6 st)

Ordspråksmusik (20 st)
Statistik

Denna sidan visar ordspråk som liknar "Based on improving new product visibility, benefits from restructuring initiatives, and near-term volume boost from Medicare Part D supports our Attractive rating for the U.S. pharmaceutical sector.".